A Phase Ib/II Trial of M7824 in Solid Tumors With Microsatellite Instability or With Consensus Molecular Subtype 4 Metastatic Colorectal Cancer
Phase of Trial: Phase I/II
Latest Information Update: 30 Nov 2018
At a glance
- Drugs MSB 0011359C (Primary)
- Indications Adenocarcinoma; Colon cancer; Colorectal cancer; Rectal cancer; Solid tumours
- Focus Therapeutic Use
- 21 Nov 2018 Planned End Date changed from 1 Nov 2020 to 1 Nov 2019.
- 07 Mar 2018 Status changed from not yet recruiting to recruiting.
- 21 Feb 2018 New trial record